Infectious Diseases – Webinars and Online Events

Explore how nanopore sequencing is revolutionizing microbial genomics! Join Richard Chalvignac as he covers NO-MISS workflows, avian flu surveillance, 16S/ITS sequencing, and more. Live Q&A included. Don’t miss this exciting webinar!

This webinar explores a microfluidics approach to quantify AMP gene expression, providing insights into potential biomarkers for early disease detection and improved treatment strategies.

The increasing implication of glial cells in neurodegenerative diseases makes them an appealing addition to iPSC-based model systems for investigating disease mechanisms.

In this webinar, Dr. Mark Pandori will join us to delve into the use of advanced molecular techniques, particularly DNA and RNA-based methods, to detect infectious agents in clinical specimens. We will explore how these innovative technologies, inclu

In our first episode of the New Frontiers in PCR Technology Series, join an exclusive Ask Me Anything with Professor Mikael Kubista. Discover how PCR is evolving with next-generation sequencing, CRISPR and microfluidics.

Recent years have witnessed a sea-change in how laboratory tests have been employed to diagnose, monitor, and manage viral infections.

As we advance through 2024, significant updates in Human Immunodeficiency Virus (HIV) and Sexually Transmitted Infections (STI) prevention and treatment are emerging. How will these developments shape future strategies in HIV and STI management?

Involved in immunotherapy research? Join our AMA Q&A with Professor Paul Moss to explore advances and applications in treating diseases. This hour-long virtual session lets you ask your questions live and dive deep into the field.

In this webinar, Dr. James Dunn will join us to discuss the process for the practical implementation of multiplex molecular assays for infectious diseases at different points of service.

Throughout the session, Dr. Dunn will also cover the role of diagnostic stewardship in ensuring patients receive testing with the appropriate diagnostic modality. There are many challenges and opportunities with the integration of molecular microbiology testing in different settings and with proper test selection and utilization, there can be significant benefits in patient outcomes.

In recent past respiratory seasons, the world witnessed a “tripledemic” of Influenza (flu), SARS-CoV-2 (COVID-19), and Respiratory Syncytial Virus (RSV). The 2024-25 landscape will likely be different, with new virus variants, new vaccines and treatments, like the game-changing antibody that protects children from RSV. The healthcare and public health community have also learned some valuable lessons going forward with the ever-evolving respiratory agents.

In this presentation, Dr. Rodney Rohde will discuss the primary microbiology, epidemiology, control, prevention, vulnerable populations, the importance of laboratory validation, and the benefits of molecular-based testing of these three primary respiratory season pathogens.